Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$196M |
| 2 |
Verizon
VZ
|
+$166M |
| 3 |
Edison International
EIX
|
+$152M |
| 4 |
PPL
PPL Corp
PPL
|
+$122M |
| 5 |
Estee Lauder
EL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ameren
AEE
|
+$140M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$136M |
| 3 |
ANDV
Andeavor
ANDV
|
+$111M |
| 4 |
LyondellBasell Industries
LYB
|
+$105M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 15.65% |
| 2 | Healthcare | 13.77% |
| 3 | Energy | 13.48% |
| 4 | Utilities | 8.99% |
| 5 | Financials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Brown-Forman Class A
BF.A
$12.7B
| $889K | ﹤0.01% |
+25,000
| New | +$810K |
|
2277
Ambev
ABEV
$44.4B
| $888K | ﹤0.01% |
119,850
-224,661
| -65% | -$1.57M |
|
|
CASC
2278
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $886K | ﹤0.01% |
49,405
-17,262
| -26% | -$283K |
|
|
QIHU
2279
PUT
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $886K | ﹤0.01% |
8,900
-20,800
| -70% | -$2.07M |
|
2280
TC Energy
TRP
$64.6B
| $884K | ﹤0.01% |
19,415
-84,864
| -81% | -$3.77M |
|
|
HOLI
2281
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $884K | ﹤0.01% |
41,052
-11,990
| -23% | -$222K |
|
2282
ArcelorMittal
MT
$56.3B
| $882K | ﹤0.01% |
23,880
-311,007
| -93% | -$11.6M |
|
|
GCVRZ
2283
DELISTED
Sanofi Contingent Value Rights
GCVRZ
| $882K | ﹤0.01% |
2,844,120
+777,120
| +38% | +$289K |
|
2284
Smith & Nephew
SNN
$12.2B
| $881K | ﹤0.01% |
+28,803
| New | +$871K |
|
2285
Skywest
SKYW
$3.84B
| $880K | ﹤0.01% |
68,944
+51,456
| +294% | +$674K |
|
|
DEST
2286
DELISTED
Destination Maternity Corporation
DEST
| $879K | ﹤0.01% |
32,078
+4,512
| +16% | +$127K |
|
|
SI
2287
CALL
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $878K | ﹤0.01% |
+6,500
| New | +$853K |
|
2288
CALL
Alaska Air
ALK
$4.71B
| $877K | ﹤0.01% |
18,800
+8,800
| +88% | +$365K |
|
|
SMA
2289
DELISTED
SYMMETRY MEDICAL INC
SMA
| $877K | ﹤0.01% |
87,190
-17,260
| -17% | -$172K |
|
2290
Boise Cascade
BCC
$2.75B
| $875K | ﹤0.01% |
+30,539
| New | +$904K |
|
2291
Ultrapar
UGP
$6.84B
| $875K | ﹤0.01% |
72,604
-172,710
| -70% | -$1.92M |
|
|
RP
2292
DELISTED
RealPage, Inc.
RP
| $875K | ﹤0.01% |
48,176
-87,202
| -64% | -$1.75M |
|
2293
Ezcorp Inc
EZPW
$2.11B
| $872K | ﹤0.01% |
80,860
+70,060
| +649% | +$821K |
|
|
TDAY
2294
USA Today Co
TDAY
$940M
| $871K | ﹤0.01% |
+58,021
| New | +$814K |
|
2295
PUT
GameStop
GME
$8.19B
| $871K | ﹤0.01% |
84,800
-146,000
| -63% | -$1.4M |
|
|
PCOM
2296
DELISTED
Points.com Inc. Common Shares
PCOM
| $865K | ﹤0.01% |
33,820
+22,792
| +207% | +$617K |
|
|
JCP
2297
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
| $862K | ﹤0.01% |
100,000
-10,600
| -10% | -$76.5K |
|
2298
PUT
Edwards Lifesciences
EW
$51.8B
| $860K | ﹤0.01% |
69,600
-271,800
| -80% | -$3.14M |
|
2299
MiMedx Group
MDXG
$657M
| $858K | ﹤0.01% |
139,927
-24,527
| -15% | -$180K |
|
2300
CALL
Bausch Health
BHC
$2.36B
| $857K | ﹤0.01% |
6,500
+2,500
| +63% | +$342K |
|
Similar funds
Israel Englander's Q1 2014 Portfolio in Review
As of Q1 2014, Israel Englander held 4,356 positions worth $34.5B, up 8.9% from $31.7B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Israel Englander deployed $4.18B of net new capital in Q1 2014, opening 945 new positions and adding to 1,266 existing holdings. Its largest new stake was Bausch Health: 575,504 shares worth $75.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 16% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Ameren, an estimated $140M trimmed.
- Israel Englander's largest Q1 2014 buy was Bausch Health: 575,504 shares worth $75.9M.
- Israel Englander added most to Devon Energy in Q1 2014, an estimated $196M increase.
- Israel Englander's biggest Q1 2014 reduction was Ameren, cutting an estimated $140M.
- Israel Englander fully exited PepsiCo in Q1 2014, selling an estimated $89.1M.
- Israel Englander's ten largest holdings make up 7.9% of its $34.5B portfolio in Q1 2014.
- Israel Englander opened 945 new positions and closed 958 in Q1 2014.
- Israel Englander's portfolio value rose 8.9% quarter-over-quarter to $34.5B.
Based on Millennium Management's 13F filing for Q1 2014, filed 15 May 2014.